Pravir Kumar

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

ACS omega

Molecular biotechnology

Cellular and molecular life sciences : CMLS

Interdisciplinary sciences, computational life sciences

Delhi Technological University

Klinikum der Johann Wolfgang Goethe-Universitat Frankfurt (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Delhi Technological University Jul 09 2015

India

Professor :: Department of Biotechnology

Tufts University School of Medicine

United States

Adjunct research instructor :: Neuology

Delhi Technological University Jul 09 2012 - Jul 09 2015

India

Associate Professor :: Biotechnology

VIT University Jan 01 2009 - Jul 06 2012

India

Associate Professor :: School of Biosciences and Technology

VIT University Nov 06 2008 - Jul 06 2012

India

Assistant Director :: Centre for Medical Engineering

VIT University Nov 07 2008 - Jan 01 2009

India

Assistant Professor :: School of Bioscience and Technology

Tufts University

United States

Research associate, Senior Research Associate, Research Instructor :: Neurology

Education History

Klinikum der Johann Wolfgang Goethe-Universitat Frankfurt Mar 15 2001 - Aug 23 2004

Germany

PHD :: Institute for Cardiovascular Physiology

Publications

Neetu Rani, Pravir Kumar
Exploring Natural Compounds as Potential CDK4 Inhibitors for Therapeutic Intervention in Neurodegenerative Diseases through Computational Analysis. Molecular biotechnology (2024)
Mehar Sahu, Neetu Rani, Pravir Kumar
Simulation and Computational Study of RING Domain Mutants of BRCA1 and Ube2k in AD/PD Pathophysiology. Molecular biotechnology 66 (5) (2024)
Mehar Sahu, Neetu Rani, Pravir Kumar
Simulation and Computational Study of RING Domain Mutants of BRCA1 and Ube2k in AD/PD Pathophysiology. Molecular biotechnology 66 (5) (2024)
Mehar Sahu, Neetu Rani, Pravir Kumar
Simulation and Computational Study of RING Domain Mutants of BRCA1 and Ube2k in AD/PD Pathophysiology. Molecular biotechnology (2024)
Sudhanshu Sharma, Pravir Kumar
Decoding the Role of MDM2 as a Potential Ubiquitin E3 Ligase and Identifying the Therapeutic Efficiency of Alkaloids against MDM2 in Combating Glioblastoma. ACS omega 8 (5) (2023)
Rahul Tripathi, Pravir Kumar
Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases. Integrative biology : quantitative biosciences from nano to macro 15 (2023)
Rohan Gupta, Dia Advani, Divya Yadav, Rashmi K Ambasta, Pravir Kumar
Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders. Molecular neurobiology (2023)
Sudhanshu Sharma, Pravir Kumar
Decoding the Role of MDM2 as a Potential Ubiquitin E3 Ligase and Identifying the Therapeutic Efficiency of Alkaloids against MDM2 in Combating Glioblastoma. ACS omega 8 (5) (2023)
Smita Kumari, Pravir Kumar
Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme. ACS omega 8 (11) (2023)
Smita Kumari, Pravir Kumar
Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme. ACS omega 8 (11) (2023)
Rahul Tripathi, Rohan Gupta, Mehar Sahu, Devesh Srivastava, Ankita Das, Rashmi K Ambasta, Pravir Kumar
Free radical biology in neurological manifestations: mechanisms to therapeutics interventions. Environmental science and pollution research international (2021)
Rohan Gupta, Rashmi K Ambasta, Pravir Kumar
Autophagy and apoptosis cascade: which is more prominent in neuronal death? Cellular and molecular life sciences : CMLS 78 (24) (2021)
Dia Advani, Pravir Kumar
Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach. ACS omega 6 (21) (2021)
Rohan Gupta, Pravir Kumar
CREB1 K292 and HINFP K330 as Putative Common Therapeutic Targets in Alzheimer's and Parkinson's Disease. ACS omega 6 (51) (2021)
Rohan Gupta, Devesh Srivastava, Mehar Sahu, Swati Tiwari, Rashmi K Ambasta, Pravir Kumar
Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Molecular diversity 25 (3) (2021)
Dhiraj Kumar, Pravir Kumar
An In-Silico Investigation of Key Lysine Residues and Their Selection for Clearing off Aβ and Holo-AβPP Through Ubiquitination. Interdisciplinary sciences, computational life sciences 11 (4) (2018)
Rashmi K Ambasta, Harleen Kohli, Pravir Kumar
Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder. Journal of translational medicine 15 (1) (2017)

Pravir Kumar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pravir Kumar